Omontys Side Effects
Generic name: peginesatide
Note: This document contains side effect information about peginesatide. Some of the dosage forms listed on this page may not apply to the brand name Omontys.
Applies to peginesatide: injectable solution
General side effects have included pyrexia (12.2%).[Ref]
Immunologic side effects have included the development of peginesatide (the active ingredient contained in Omontys) specific antibodies (1.2%).[Ref]
Other side effects have included arteriovenous fistula site complication (16.1%).[Ref]
Hypersensitivity side effects have included postmarketing reports of serious allergic reactions including fatal reactions (0.02%).
1. "Product Information. Omontys (peginesatide)." Takeda Pharmaceuticals America, Lincolnshire, IL.
Medically reviewed by Drugs.com. Last updated on Aug 15, 2020.
More about Omontys (peginesatide)
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Interactions
- Drug class: recombinant human erythropoietins
- FDA Approval History
Related treatment guides
Some side effects may not be reported. You may report them to the FDA.